Market Reports
published on Jun 28, 2024
Report Overview:
This report is an analysis of the results from a survey of 60 pharmaceuticals enterprises carried out by NelsonHall.
Who is this Report for:
NelsonHall’s “Operational Transformation Pressures & Initiatives – Pharmaceuticals” report assists organizations in understanding the operational transformation requirements and initiatives of the pharmaceuticals sector.
This report is an analysis of the results from a survey of 60 pharmaceuticals enterprises carried out by NelsonHall.
The report is designed for:
- CXOs within the pharmaceuticals sector looking to understand developments within the sector and the operational transformation and BPS initiatives planned by their peers
- Vendor marketing, sales, and business managers wishing to understand the initiatives needed by the pharmaceuticals sector
- Financial analysts and investors specializing in the services sector who are looking to understand the operational transformation pressures and initiatives within the pharmaceuticals sector.
Scope of this Report:
The report analyzes the operational transformation requirements and initiatives of the pharmaceuticals sector and covers:
- Assessments of the adequacy of current operating models and processes to support the organization’s business strategy
- The level of need for operational transformation overall and by process
- The benefits sought by pharmaceuticals companies from operational transformation
- The operational transformation initiatives planned by pharmaceuticals companies
- The extent to which pharmaceuticals companies will adopt standalone transformation vs. outsourcing as a transformation enabler
- The key technology-related transformation initiatives planned.
The sectors covered in this series include:
- Banking
- Life & health insurance
- P&C insurance
- Healthcare Provider
- Energy
- Utilities
- High-tech
- Automotive
- CPG
- Pharmaceuticals
- Retail
- Logistics
- Travel & transport
- Telecoms
- Media.
The regions covered include:
- U.S.
- U.K.
- Continental Europe.
Key Findings & Highlights:
NelsonHall’s analysis of Operational Transformation & BPS Requirements for Pharmaceuticals enterprises consists of 23 pages. The report identifies that:
- Operational transformation is highly important to 90% of pharmaceuticals companies
- Less than half of current operating models and processes in the pharmaceuticals sector are highly adequate to support the organization’s strategy in a number of business-critical areas
- The current economic environment is increasing pharmaceuticals companies’ needs for operational cost reduction and automation of manual processes.
This report is one of a series of detailed individual sector reports on operational transformation published by NelsonHall.